Actively Recruiting
Chinese Atrial Fibrillation Registry
Led by Beijing Anzhen Hospital · Updated on 2025-05-23
100000
Participants Needed
2
Research Sites
1274 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective, observational cohort study aims to establish a long-term registry of adult patients with atrial fibrillation (AF) in China to comprehensively characterize patient profiles and evaluate real-world management and outcomes over time. The objectives of the study are to: * Describe the demographic, clinical, and treatment characteristics of AF patients across different stages of disease progression. * Assess the effectiveness and safety of various AF treatment strategies, including oral anticoagulation, catheter ablation, and left atrial appendage closure, in routine clinical practice. * Identify patient- and treatment-related factors that influence therapeutic outcomes. * Explore the role of advanced technologies and artificial intelligence in improving procedural performance, risk stratification, and clinical decision-making in AF care. Participants will undergo standardized baseline evaluation and longitudinal follow-up to collect data on heart rhythm monitoring, treatment exposures, healthcare utilization, clinical events, and patient-reported outcomes. This cohort will generate real-world evidence to inform personalized and evidence-based management of AF.
CONDITIONS
Official Title
Chinese Atrial Fibrillation Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Documented atrial fibrillation episode lasting more than 30 seconds confirmed by ECG, Holter monitor, implantable cardiac monitor, or wearable ECG device
- Signed informed consent and willingness to participate in follow-up
You will not qualify if you...
- Atrial fibrillation due to a reversible cause (e.g., transient secondary AF)
- Presence of comorbid conditions associated with an expected life expectancy of less than 1 year
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Beijing Anzhen Hospital
Beijing, Beijing Municipality, China, 100029
Actively Recruiting
2
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China, 310009
Actively Recruiting
Research Team
L
Liu He, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here